enrofloxacin has been researched along with E coli Infections in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (14.81) | 18.2507 |
2000's | 27 (33.33) | 29.6817 |
2010's | 37 (45.68) | 24.3611 |
2020's | 5 (6.17) | 2.80 |
Authors | Studies |
---|---|
Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Barr, JJ; Dai, J; Li, J; Ren, J; Subedi, D; Tang, F; Wang, Y; Wu, J; Xue, F | 1 |
Do, KH; Lee, WK; Seo, K | 1 |
Albarracin, B; Altier, C; Cazer, C; Gröhn, YT; Osman, M | 1 |
Arsenault, J; de Lagarde, M; Desmarais, G; Fairbrother, JM; Kohan-Ghadr, HR; Vanier, G | 1 |
Altier, C; Dulièpre, SC; Foditsch, C; Garzon, A; Pereira, RV; Siler, JD; Warnick, LD | 1 |
Balsliemke, J; Carl, A; Eisenberger, D; Kämpf, P; Nickel, S; Schulze, G; Valenza, G | 1 |
Berrios, R; Domig, KJ; Doupovec, B; Gierus, M; Mayrhofer, S; Roth, N; Schwarz, C; Weingut, C | 1 |
Kaspar, H; Kietzmann, M; Meißner, J; Reupke, S; Römer, A; Scherz, G; Wallmann, J | 1 |
Chuppava, B; Keller, B; Kietzmann, M; Meißner, J; Visscher, C | 1 |
Higuchi, M; Kanai, N; Kawai, K; Kayasaki, F; Kondo, H; Kondo, N; Mukai, T; Sasaki, Y; Sawaguchi, N; Shinozuka, Y; Sugimoto, K; Takeda, A; Watanabe, A; Yamada, M; Yasuda, A | 1 |
Boyen, F; Chantziaras, I; Damiaans, B; Dewulf, J; Filippitzi, ME; Haesebrouck, F; Smet, A | 1 |
Behringer, MG; Boothe, DM; Thungrat, K | 1 |
Chuppava, B; El-Wahab, AA; Keller, B; Kietzmann, M; Meißner, J; Visscher, C | 1 |
Bousquet, E; Mascaron, L; Szuster-Ciesielska, A; Urban-Chmiel, R; Wasak, M; Wernicki, A | 1 |
Arslan, E; Buyukcangaz, E; Cengiz, M; Sahinturk, P; Sen, A; Sonal, S | 1 |
Daniels, JB; Irom, SJ; Lakritz, J; Tracy, G | 1 |
Dheilly, A; Jouy, E; Kempf, I; Le Devendec, L; Mourand, G | 1 |
Biasi, G; Bonilauri, P; Dottori, M; Gherpelli, Y; Luppi, A; Maioli, G; Martelli, P; Merialdi, G | 1 |
Bughio, S; Dai, X; Guo, M; Ren, W; Sun, Y; Wang, L; Zhang, Y | 1 |
Batzias, G; Kaltsogianni, F; Koutinas, A; Miriagou, V; Saridomichelakis, MN; Sianou, E; Siarkou, VI; Sofianou, D; Tzavaras, I; Tzelepi, E; Vingopoulou, EI | 1 |
Cagnardi, P; Ferraresi, C; Giacomelli, M; Grilli, G; Intorre, L; Lucatello, L; Meucci, V; Montesissa, C; Piccirillo, A | 1 |
Bandyopadhyay, S; Francis, KP; Hod, EA; Karolewski, B; Papich, MG; Prestia, KA; Slate, AR | 1 |
Bushman, W; Hutson, PR; Wong, L | 1 |
Adams, EL; Johns, IC | 1 |
Katholm, J; Landin, H; Mörk, MJ; Persson, Y | 1 |
Altier, C; Aprea, VA; Cummings, KJ | 1 |
Fink-Gremmels, J; Haritova, AM; Lashev, LD; Rusenov, AG; Rusenova, NV; Schrickx, J | 1 |
Beaudry, F; Béraud, R; Bernier, D; del Castillo, JR; Huneault, L; Letellier, A | 1 |
Madec, JY; Maurer, C; Meunier, D | 1 |
Boothe, DM; Johnson, CM; Kaltenboeck, B; Shaheen, BW; Wang, C | 1 |
Duchateau, L; Froyman, R; Garmyn, A; Haesebrouck, F; Martel, A; Nauwynck, H; Pasmans, F | 1 |
Donoghue, AM; Huff, GR; Huff, WE; Rath, NC | 1 |
Kaartinen, L; Mustonen, K; Pyörälä, S; Simojoki, H; Suojala, L | 1 |
Boothe, DM; Hubka, P | 1 |
Bouder, A; Dheilly, A; Hellard, G; Kempf, I; Le Devendec, L | 1 |
Koenders, BB; Schuurmans, JM; Smid, MC; ter Kuile, BH; van der Horst, MA | 1 |
Haritova, A; Lashev, L; Lutckanov, M; Petrov, V; Urumova, V | 1 |
Choi, MJ; Damte, D; Gebru, E; Lee, SJ; Park, SC | 1 |
Choi, MJ; Damte, D; Gebru, E; Kim, YH; Lee, SJ; Park, SC | 1 |
Bouder, A; Dheilly, A; Jouy, E; Kempf, I; Le Devendec, L; Mourand, G | 1 |
Barbieri, R; Bergagna, S; Coppo, E; Debbia, E; Dondo, A; Marchese, A; Pruzzo, C; Rossi, F; Zoppi, S | 1 |
Astrofsky, KM; Buckley, EM; Fox, JG; García, A; Madden, CM; Morgan, PB; Parry, NM; Swennes, AG | 1 |
Carvalho, VM; Catão-Dias, JL; Irino, K; Lopez, RP; Osugui, L; Pestana de Castro, AF; Setzer, AP | 1 |
Díaz-Sánchez, S; Ewers, C; Höfle, U; Sánchez, S | 1 |
Cagnardi, P; Di Leva, V; Giovanardi, D; Lucatello, L; Montesissa, C; Ortali, G; Russo, E | 1 |
Fujii, N; Ishihara, K; Muramatsu, Y; Okubo, T; Sato, T; Tamura, Y; Ueno, H; Yokota, S | 1 |
Asai, T; Ozawa, M | 1 |
Cooke, CL; Hirsh, DC; Jang, SS; Singer, RS | 1 |
Baker, JD; Cope, CV; Farrell, DE; Myers, MJ; Post, LO | 1 |
Kaartinen, L; Kutila, T; Lehtolainen, T; Pyörälä, S; Saloniemi, H; Seppälä, K; Suojala, L; Tähti, M | 1 |
Nagatomo, H; Sueyoshi, M; Taura, Y; Uemura, R | 1 |
Glisson, JR; Hofacre, CL; Mathis, GF | 1 |
Balog, JM; Donoghue, AM; Huff, GR; Huff, WE; Rath, NC | 1 |
Bisgaard, M; Christensen, JP; Kuhnert, P; Olsen, JE; Petersen, A | 1 |
Elmas, M; Er Karabacak, A; Uney, K; Yazar, E | 1 |
Chiers, K; Decostere, A; Duchateau, L; Froyman, R; Marien, M; Nauwynck, H | 1 |
Lazizzera, C; Madec, JY; Maurer, C | 1 |
De La Fuente, R; Domínguez-Bernal, G; Horcajo, P; Jurado, S; Martínez-Pulgarín, S; Orden, JA; Ruiz-Santa-Quiteria, JA | 1 |
McClure, JT; Meinen, JB; Rosin, E | 1 |
Barsanti, J; Budsberg, SC; Dorfman, M | 1 |
Batt, RM; Elwood, CM; Rutgers, HC; Simpson, KW; Stepien, RL | 1 |
Bertschinger, HU; Stamm, M; Vögeli, P | 1 |
Fang, W; Pyörälä, S | 1 |
Farca, AM; Maffei, F; Piromalli, G; Re, G | 1 |
Burvenich, C; Heyneman, R; Hoeben, D | 1 |
Kyriakis, SC; Lekkas, S; Petridou, E; Sarris, K; Tsiloyiannis, VK; Vlemmas, J | 2 |
Brumbaugh, GW; Lizarraga, RE; Ocampo, CL; Sumano, LH | 1 |
Burvenich, C; Massart-Leën, AM; Monfardini, E; Paape, MJ; Smits, E | 1 |
Eklund, K; Hirvonen, J; Huszenicza, G; Kulcsar, M; Pyörälä, S; Saloniemi, H; Teppo, AM | 1 |
Soliman, GA | 1 |
Martín, M; Mateu, E | 1 |
Burvenich, C; Hamann, J; Hoeben, BD; Monfardini, E | 1 |
Burke, TJ; Campbell, KL; Kakoma, I; Kim, CH; Koo, HY; McKiernan, BC; Oluoch, AO; Siegel, AM; Weisiger, RM | 1 |
Bjorling, D; Fialkowski, JP; Lautzenhiser, SJ; Rosin, E | 1 |
Kyriakis, SC; Sarris, K; Tsiloyiannis, VK; Vlemmas, J | 1 |
Tsukahara, T; Ushida, K | 1 |
Goering, RV | 1 |
Burvenich, C; Dosogne, H; Massart-Leën, AM; Meyer, E; Sturk, A; van Loon, J | 1 |
10 trial(s) available for enrofloxacin and E coli Infections
Article | Year |
---|---|
Randomized clinical trial to evaluate the effectiveness of enrofloxacin as a second-line antibiotic for treatment of acute Escherichia coli mastitis.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Appetite; Cattle; Cattle Diseases; Disease Progression; Drug Therapy, Combination; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Kanamycin; Mastitis; Oxytetracycline; Retreatment; Time Factors; Treatment Failure; Treatment Outcome | 2018 |
Efficacy of enrofloxacin for the treatment of acute clinical mastitis caused by Escherichia coli in dairy cows.
Topics: Animals; Anti-Infective Agents; Cattle; Cell Count; Double-Blind Method; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Follow-Up Studies; Mastitis, Bovine; Milk; Survival Analysis; Time Factors; Treatment Outcome | 2015 |
Effects of fluoroquinolone treatment on MDR1 and MRP2 mRNA expression in Escherichia coli-infected chickens.
Topics: Animals; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Chickens; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Gene Expression Regulation; Male; Poultry Diseases; RNA, Messenger | 2008 |
The efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis.
Topics: Administration, Oral; Animals; Cattle; Dairying; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Lactoferrin; Mammary Glands, Animal; Mastitis, Bovine; Milk; Quinolones; Severity of Illness Index; Treatment Outcome | 2004 |
Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Chickens; Combined Modality Therapy; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Male; Poultry Diseases; Quinolones | 2004 |
Efficacy of enrofloxacin, florfenicol and amoxicillin against Ornithobacterium rhinotracheale and Escherichia coli O2:K1 dual infection in turkeys following APV priming.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Area Under Curve; Body Weight; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Flavobacteriaceae Infections; Fluoroquinolones; Metapneumovirus; Microbial Sensitivity Tests; Ornithobacterium; Paramyxoviridae Infections; Poultry Diseases; Respiratory Tract Diseases; Specific Pathogen-Free Organisms; Thiamphenicol; Trachea; Turkeys | 2007 |
The efficacy of enrofloxacin in-feed medication, by applying different programmes for the control of post weaning diarrhoea syndrome of piglets.
Topics: Animal Feed; Animals; Anti-Infective Agents; Diarrhea; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Quinolones; Swine; Swine Diseases; Syndrome | 1997 |
The efficacy of enrofloxacin in-feed medication by applying different programmes for the control of post weaning oedema disease in weaned piglets.
Topics: Animal Feed; Animals; Anti-Infective Agents; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema Disease of Swine; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Quinolones; Swine | 1997 |
Effectiveness of two fluoroquinolones for the treatment of chronic respiratory disease outbreak in broilers.
Topics: Animals; Anti-Infective Agents; Body Weight; Chickens; Chronic Disease; Disease Outbreaks; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Mycoplasma Infections; Nicotinic Acids; Norfloxacin; Poultry Diseases; Probability; Quinolones; Respiratory Tract Infections; Survival Analysis | 1998 |
The effect of organic acids on the control of post-weaning oedema disease of piglets.
Topics: Animal Feed; Animals; Anti-Infective Agents; Body Weight; Citric Acid; Dietary Supplements; Edema Disease of Swine; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Intestine, Small; Lactic Acid; Male; Quinolones; Swine | 2001 |
71 other study(ies) available for enrofloxacin and E coli Infections
Article | Year |
---|---|
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Phage Cocktail Targeting STEC O157:H7 Has Comparable Efficacy and Superior Recovery Compared with Enrofloxacin in an Enteric Murine Model.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Disease Models, Animal; Enrofloxacin; Escherichia coli Infections; Escherichia coli O157; Mice; Shiga-Toxigenic Escherichia coli | 2022 |
Molecular characteristics of fluoroquinolone-resistant Escherichia coli isolated from suckling piglets with colibacillosis.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; DNA Gyrase; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Norfloxacin; Quinolones; Sulfonamides; Swine | 2022 |
Antimicrobial resistance trends among canine Escherichia coli isolated at a New York veterinary diagnostic laboratory between 2007 and 2020.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; New York; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
A new multidrug-resistant enterotoxigenic Escherichia coli pulsed-field gel electrophoresis cluster associated with enrofloxacin non-susceptibility in diseased pigs.
Topics: Animals; Canada; Databases, Factual; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Phylogeny; Swine; Swine Diseases; Virulence Factors | 2021 |
Genotypic antimicrobial resistance characterization of E. coli from dairy calves at high risk of respiratory disease administered enrofloxacin or tulathromycin.
Topics: Animals; Anti-Bacterial Agents; Cattle; Disaccharides; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Feces; Genome, Bacterial; Genotype; Heterocyclic Compounds; Longitudinal Studies; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA | 2020 |
Molecular Characterization of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Milk Samples of Dairy Cows with Mastitis in Bavaria, Germany.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Cattle; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Germany; Mastitis, Bovine; Milk; Multilocus Sequence Typing | 2018 |
Effect of an organic acids based feed additive and enrofloxacin on the prevalence of antibiotic-resistant E. coli in cecum of broilers.
Topics: Acetic Acid; Animal Feed; Animals; Anti-Bacterial Agents; Cecum; Chickens; Diet; Dietary Supplements; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Formates; Male; Poultry Diseases; Prevalence; Propionates; Random Allocation | 2017 |
Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica).
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Susceptibility; Enrofloxacin; Escherichia coli Infections; Feces; Fluoroquinolones; Injections, Intramuscular; Microbial Sensitivity Tests; Swine; Swine Diseases | 2017 |
Effects of different types of flooring design on the development of antimicrobial resistance in commensal Escherichia coli in fattening turkeys.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Floors and Floorcoverings; Fluoroquinolones; Housing, Animal; Microbial Sensitivity Tests; Poultry Diseases; Symbiosis; Turkeys | 2018 |
The effect of a commercial competitive exclusion product on the selection of enrofloxacin resistance in commensal E. coli in broilers.
Topics: Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Poultry Diseases | 2018 |
Evaluation of a fluorescence resonance energy transfer quantitative polymerase chain reaction assay for identification of gyrA mutations conferring enrofloxacin resistance in canine urinary Escherichia coli isolates and canine urine specimens.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; DNA Gyrase; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; False Positive Reactions; Fluorescence Resonance Energy Transfer; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Reproducibility of Results | 2018 |
Resistance of
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Floors and Floorcoverings; Housing, Animal; Microbial Sensitivity Tests; Poultry Diseases; Turkeys | 2018 |
Evaluation of the ability of colistin, amoxicillin (components of Potencil
Topics: A549 Cells; Amoxicillin; Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Ciprofloxacin; Colistin; Dose-Response Relationship, Drug; Drug Combinations; Enrofloxacin; Escherichia coli Infections; Humans; In Vitro Techniques; Lipopolysaccharides; Shiga Toxin; Shiga-Toxigenic Escherichia coli; Vero Cells | 2019 |
In vitro bactericidal activity of enrofloxacin against gyrA mutant and qnr-containing Escherichia coli isolates from animals.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Colony Count, Microbial; DNA Gyrase; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Microbial Sensitivity Tests; Mutation | 2013 |
Fluoroquinolone levels in healthy dog urine following a 20-mg/kg oral dose of enrofloxacin exceed mutant prevention concentration targets against Escherichia coli isolated from canine urinary tract infections.
Topics: Animals; Antineoplastic Agents; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Mutation; Urinary Tract Infections | 2014 |
Antimicrobial resistance selection in avian pathogenic E. coli during treatment.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Bacterial; Drug Therapy, Combination; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Oxytetracycline; Poultry Diseases | 2013 |
Antimicrobial resistance of F4+ Escherichia coli isolated from Swine in Italy.
Topics: Animals; Anti-Bacterial Agents; Antigens, Bacterial; Cephalosporins; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fimbriae Proteins; Fluoroquinolones; Italy; Swine; Swine Diseases; Thiamphenicol | 2015 |
E. coli infection modulates the pharmacokinetics of oral enrofloxacin by targeting P-glycoprotein in small intestine and CYP450 3A in liver and kidney of broilers.
Topics: Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Avian Proteins; Chickens; Cytochrome P450 Family 3; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Intestinal Diseases; Intestinal Mucosa; Intestines; Kidney; Liver; Male; Poultry Diseases; Verapamil | 2014 |
Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Cefoxitin; Ceftazidime; Cephalosporins; Dermatitis, Atopic; DNA Gyrase; DNA Topoisomerase IV; Dogs; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Otitis; Plasmids | 2014 |
Enrofloxacin against Escherichia coli in turkeys: which treatment scheme is effective?
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Chromatography, Liquid; Dose-Response Relationship, Drug; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Microbial Sensitivity Tests; Poultry Diseases; Tandem Mass Spectrometry; Turkeys | 2014 |
Efficacy of enrofloxacin in a mouse model of sepsis.
Topics: Administration, Intravenous; Administration, Oral; Animals; Anti-Bacterial Agents; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Male; Mice; Sepsis | 2014 |
Resolution of chronic bacterial-induced prostatic inflammation reverses established fibrosis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Chromatography, High Pressure Liquid; Collagen; Disease Models, Animal; Enrofloxacin; Escherichia coli Infections; Fibrosis; Fluoroquinolones; Hydroxyproline; Male; Mice, Inbred C3H; Prostate; Prostatitis | 2015 |
Trends in antimicrobial resistance in equine bacterial isolates: 1999-2012.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Horse Diseases; Horses; Microbial Sensitivity Tests; Penicillin G; Streptococcus; Streptococcus equi; Sulfamethizole; Tetracyclines; Trimethoprim; United Kingdom | 2015 |
Antimicrobial resistance trends among canine Escherichia coli isolates obtained from clinical samples in the northeastern USA, 2004-2011.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Logistic Models; Multivariate Analysis; New England; Tetracycline; Time Factors | 2015 |
Comparison of the selection of antimicrobial resistance in fecal Escherichia coli during enrofloxacin administration with a local drug delivery system or with intramuscular injections in a swine model.
Topics: Animals; Anti-Bacterial Agents; Disease Reservoirs; Drug Implants; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Injections, Intramuscular; Microbial Sensitivity Tests; Random Allocation; Selection, Genetic; Swine; Swine Diseases; Treatment Outcome | 2008 |
Shiga toxin Stx2 production is promoted by enrofloxacin in experimental in vitro-selected mutants of Escherichia coli O157:H7 resistant to fluoroquinolones.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Drug Resistance, Bacterial; Enrofloxacin; Enzyme-Linked Immunosorbent Assay; Escherichia coli Infections; Escherichia coli O157; Fluoroquinolones; Food Microbiology; Mutation; Shiga Toxin 2 | 2009 |
Detection of fluoroquinolone resistance level in clinical canine and feline Escherichia coli pathogens using rapid real-time PCR assay.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; DNA Gyrase; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluorescence Resonance Energy Transfer; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Urine | 2009 |
Effect of multiple- and single-day enrofloxacin medications against dual experimental infection with avian pneumovirus and Escherichia coli in turkeys.
Topics: Animals; Anti-Infective Agents; Colony Count, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Male; Metapneumovirus; Paramyxoviridae Infections; Poultry Diseases; Specific Pathogen-Free Organisms; Turkeys; Viral Load | 2009 |
Immune interference of bacteriophage efficacy when treating colibacillosis in poultry.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Chickens; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Male; Poultry Diseases | 2010 |
Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis.
Topics: Acetylglucosaminidase; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Ketoprofen; Lactation; Mastitis, Bovine; Milk; Random Allocation; Treatment Outcome | 2010 |
In vitro susceptibility of canine and feline Escherichia coli to fosfomycin.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cats; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Fosfomycin; Microbial Sensitivity Tests; Phenotype; Urine | 2011 |
Clinical and microbial efficacy of antimicrobial treatments of experimental avian colibacillosis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Male; Oxytetracycline; Plasmids; Poultry Diseases; Sulfadimethoxine; Trimethoprim | 2011 |
De novo acquisition of resistance to three antibiotics by Escherichia coli.
Topics: Adaptation, Biological; Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Tetracycline | 2011 |
Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78/H12 infected chickens.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Biological Availability; Biomarkers; Chickens; Ciprofloxacin; Dose-Response Relationship, Drug; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Quercetin; Tissue Distribution | 2011 |
Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.
Topics: Animals; Anti-Bacterial Agents; DNA, Bacterial; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Selection, Genetic; Sequence Analysis, DNA; Time Factors | 2011 |
Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Base Sequence; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation | 2012 |
Resistance gene transfer during treatments for experimental avian colibacillosis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Bird Diseases; Chickens; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Fluoroquinolones; Gene Transfer, Horizontal; Microbial Sensitivity Tests; Oxytetracycline; Plasmids; Sulfadimethoxine; Trimethoprim | 2012 |
Characterization of fluoroquinolone-resistant Escherichia coli causing septicemic colibacillosis in calves in Italy: emergence of a multiresistant O78 clonal group.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cattle; Cattle Diseases; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Incidence; Italy; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Random Amplified Polymorphic DNA Technique | 2012 |
Enzootic enteropathogenic Escherichia coli infection in laboratory rabbits.
Topics: Animals; Animals, Laboratory; Anti-Bacterial Agents; Cell Adhesion; Cell Line; Diarrhea; Disease Outbreaks; DNA, Bacterial; Enrofloxacin; Enteropathogenic Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Hepatocytes; Humans; Male; Molecular Sequence Data; Molecular Typing; Netherlands; Rabbits; Sequence Analysis, DNA; Serotyping | 2012 |
Characterization of extraintestinal pathogenic Escherichia coli isolated from captive wild felids with bacteremia.
Topics: Animals; Animals, Zoo; Anti-Bacterial Agents; Bacteremia; Enrofloxacin; Escherichia coli Infections; Fatal Outcome; Felidae; Female; Fluoroquinolones; Male; Urinary Tract Infections | 2012 |
Occurrence of avian pathogenic Escherichia coli and antimicrobial-resistant E. coli in red-legged partridges (Alectoris rufa): sanitary concerns of farming.
Topics: Animal Husbandry; Animals; Animals, Domestic; Animals, Wild; Anti-Bacterial Agents; Bird Diseases; Cefotaxime; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Galliformes; Gentamicins; Humans; Microbial Sensitivity Tests; Phenotype; Prevalence; Spain | 2012 |
Approved medication of water with enrofloxacin to treat turkey colibacillosis: assessment of efficacy using a PK/PD approach.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Male; Microbial Sensitivity Tests; Poultry Diseases; Turkeys; Water | 2012 |
Contribution of the AcrAB-TolC efflux pump to high-level fluoroquinolone resistance in Escherichia coli isolated from dogs and humans.
Topics: Animals; Anti-Infective Agents; DNA, Bacterial; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Lipoproteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2013 |
Relationships between mutant prevention concentrations and mutation frequencies against enrofloxacin for avian pathogenic Escherichia coli isolates.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Chickens; DNA Gyrase; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Japan; Microbial Sensitivity Tests; Mutation; Poultry Diseases; Selection, Genetic | 2013 |
Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections.
Topics: Animals; Anti-Infective Agents; Bacteriuria; Chromosome Banding; DNA, Bacterial; Dog Diseases; Dogs; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Quinolones; Urinary Tract Infections | 2002 |
The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine.
Topics: Animals; Anti-Infective Agents; Creatinine; Dexamethasone; Endotoxins; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Male; Quinolones; Swine | 2003 |
Effect of antimicrobial agents on the production and release of shiga toxin by enterotoxaemic Escherichia coli isolates from pigs.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Wall; Colistin; Edema Disease of Swine; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Fosfomycin; Gentamicins; Quinolones; Shiga Toxin 2; Sus scrofa; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Comparative efficacy of enrofloxacin, oxytetracycline, and sulfadimethoxine for the control of morbidity and mortality caused by Escherichia coli in broiler chickens.
Topics: Air Sacs; Analysis of Variance; Animals; Anti-Bacterial Agents; Body Weight; Chickens; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Oxytetracycline; Poultry Diseases; Quinolones; Sulfadimethoxine; Treatment Outcome | 2004 |
Vertical transmission of a fluoroquinolone-resistant Escherichia coli within an integrated broiler operation.
Topics: Animals; Anti-Bacterial Agents; Chickens; Denmark; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Infectious Disease Transmission, Vertical; Mutation; Ovum; Poultry Diseases; Virulence | 2006 |
Influence of Escherichia coli endotoxin-induced endotoxaemia on the pharmacokinetics of enrofloxacin after intravenous administration in rabbits.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Endotoxemia; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Injections, Intravenous; Lipopolysaccharides; Male; Rabbits; Random Allocation | 2006 |
Characterization of inducible stx2-positive Escherichia coli O157:H7/H7- strains isolated from cattle in France.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Enzyme-Linked Immunosorbent Assay; Escherichia coli Infections; Escherichia coli O157; Fluoroquinolones; Food Microbiology; France; Microbial Sensitivity Tests; Shiga Toxin 2; Species Specificity; Spectrophotometry | 2008 |
Characterization of fluoroquinolone resistance in Escherichia coli strains from ruminants.
Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Sheep; Sheep Diseases | 2008 |
Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections.
Topics: Animals; Anti-Infective Agents; Biotransformation; Cyclophosphamide; Dogs; Dose-Response Relationship, Drug; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Male; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Neutropenia; Quinolones; Species Specificity; Staphylococcal Infections | 1995 |
Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Dogs; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Male; Prostate; Prostatitis; Quinolones | 1995 |
Enrofloxacin treatment of gram-negative infections.
Topics: Animals; Anti-Infective Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Gram-Negative Bacterial Infections; Pseudomonas Infections; Quinolones; Salmonella Infections, Animal | 1994 |
Inheritance of resistance to oedema disease in the pig: experiments with an Escherichia coli strain expressing fimbriae 107.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Colony-Forming Units Assay; Crosses, Genetic; Edema Disease of Swine; Enrofloxacin; Escherichia coli Infections; Feces; Female; Fluoroquinolones; Genetic Predisposition to Disease; Genotype; Immunity, Innate; Male; Quinolones; Specific Pathogen-Free Organisms; Swine; Weaning | 1993 |
Mastitis-causing Escherichia coli: serum sensitivity and susceptibility to selected antibacterials in milk.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Blood Bactericidal Activity; Cattle; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gentamicins; Glucuronidase; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Quinolones; Sulfadoxine; Tetracycline; Trimethoprim | 1996 |
Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Buffers; Cephaloridine; Cephalosporins; Cystitis; Dermatitis; Dog Diseases; Dogs; Drug Synergism; Edetic Acid; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Kanamycin; Male; Otitis; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Quinolones; Staphylococcal Infections; Time Factors; Tromethamine | 1997 |
Influence of antimicrobial agents on bactericidal activity of bovine milk polymorphonuclear leukocytes.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cattle; Cattle Diseases; Cell-Free System; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; In Vitro Techniques; Luminescent Measurements; Mastitis; Milk; Neutrophils; Peroxidase; Quinolones; Respiratory Burst; Superoxides | 1997 |
Effect of antibiotic induced bacterial clearance in the udder on L-selectin shedding of blood neutrophils in cows with Escherichia coli mastitis.
Topics: Animals; Anti-Infective Agents; Cattle; Colony Count, Microbial; Enrofloxacin; Escherichia coli Infections; Female; Flow Cytometry; Fluoroquinolones; L-Selectin; Leukocyte Count; Mammary Glands, Animal; Mastitis, Bovine; Neutrophils; Quinolones | 1999 |
Acute phase response in dairy cows with experimentally induced Escherichia coli mastitis.
Topics: Acute-Phase Reaction; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Clonixin; Colony Count, Microbial; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Haptoglobins; Hydrocortisone; Mastitis, Bovine; Milk; Nitrites; Quinolones; Random Allocation; Serum Amyloid A Protein; Tumor Necrosis Factor-alpha | 1999 |
Tissue distribution and disposition kinetics of enrofloxacin in healthy and E. coli infected broilers.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Chickens; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Half-Life; Metabolic Clearance Rate; Poultry Diseases; Quinolones; Tissue Distribution | 2000 |
Antimicrobial resistance in enteric porcine Escherichia coli strains in Spain.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Cephalosporins; Colistin; Diarrhea; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Nebramycin; Neomycin; Quinolones; Spain; Swine; Swine Diseases | 2000 |
Treatment of acute Escherichia coli mastitis in cows with enrofloxacin: effect on clinical signs and chemiluminescence of circulating neutrophils.
Topics: Animals; Anti-Infective Agents; Cattle; Cell Count; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Lactation; Luminescent Measurements; Mastitis, Bovine; Milk; Neutrophils; Quinolones | 2000 |
Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998).
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gentamicins; Infections; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Respiratory System; Retrospective Studies; Skin; Urine | 2001 |
In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Drug Combinations; Drug Synergism; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 2001 |
Organic acid profiles in feces of pigs with pathogenic or non-pathogenic diarrhea.
Topics: Animals; Anti-Infective Agents; Diarrhea; Dyspepsia; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Feces; Female; Fluoroquinolones; Lactic Acid; Male; Quinolones; Succinic Acid; Swine; Swine Diseases | 2001 |
Questions study on Escherichia coli susceptibility.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 2002 |
Effect of enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis.
Topics: Animals; Anti-Infective Agents; Cattle; Cell Count; Endotoxins; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Mastitis, Bovine; Milk; Quinolones | 2002 |